The invention relates to immunomodulators. In particular the invention relates to specific immunomodulators based on the superantigen SMEZ-2 and more particularly based on mutants of the superantigen SMEZ-2, which are adapted to target antigen-presenting-cells for the purpose of enhancing or suppressing a host immune response.

 
Web www.patentalert.com

< T24 antigen for immunodiagnosis of Taenia solium cysticercosis

> In vitro method for the diagnosis of neurodegenerative diseases

> Feline immunoglobulin E molecules and related methods
~ 00527